Open AccessAbstract CT054: The development of a personalized autologous clonal neoantigen T cell therapy for the treatment of solid cancer using the VELOSTM manufacturing platform generates highly potent and reactive CD8+ and CD4+ T cells for clinical use
Author(s) -
Henrieta Fraser,
Rebecca Pike,
Sarah Thirkell,
Asiya Arshad,
Sam Jide-Banwo,
Hollie Bartley,
Evi Rologi,
Michał Przemysław Pruchniak,
Shreenal Patel,
Jennine Mootien,
Jane Robertson,
Andrew W.B. Craig,
Max Salm,
Katy Newton,
Luke Goodsell,
Fong Chun Chan,
Gareth A. Wilson,
Carlos S. Frenk,
Iraj Ali,
Karl S. Peggs,
Mark W. Lowdell,
Lyra Del Rosio,
Andrew Hayes,
Samra Turajlic,
Farah Islam,
David Lawrence,
Mariam JamalHanjani,
Martin Förster,
Edward Samuel
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-ct054
Subject(s) - cancer , cd8 , medicine , immunotherapy , cancer research , t cell , antigen , oncology , immunology , immune system